Thomas M. Ross - 03 Jan 2023 Form 4 Insider Report for MAXCYTE, INC. (MXCT)

Signature
/s/ Brian F. Leaf, attorney-in-fact
Issuer symbol
MXCT
Transactions as of
03 Jan 2023
Net transactions value
-$119,413
Form type
4
Filing time
05 Jan 2023, 16:31:00 UTC
Previous filing
06 Dec 2022
Next filing
03 Feb 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MXCT Common Stock Options Exercise $10,334 +10,513 $0.9830 10,513 03 Jan 2023 Direct F1
transaction MXCT Common Stock Sale $53,932 -10,513 -100% $5.13 0 03 Jan 2023 Direct F1, F2
transaction MXCT Common Stock Options Exercise $8,997 +9,153 $0.9830 9,153 04 Jan 2023 Direct F1
transaction MXCT Common Stock Sale $46,406 -9,153 -100% $5.07 0 04 Jan 2023 Direct F1, F3
transaction MXCT Common Stock Options Exercise $9,306 +9,467 $0.9830 9,467 05 Jan 2023 Direct F1
transaction MXCT Common Stock Sale $47,714 -9,467 -100% $5.04 0 05 Jan 2023 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MXCT Employee Stock Option (right to buy) Options Exercise $0 -10,513 -33% $0.000000 21,088 03 Jan 2023 Common Stock 10,513 $0.9830 Direct F1, F5
transaction MXCT Employee Stock Option (right to buy) Options Exercise $0 -9,153 -43% $0.000000 11,935 04 Jan 2023 Common Stock 9,153 $0.9830 Direct F1, F5
transaction MXCT Employee Stock Option (right to buy) Options Exercise $0 -9,467 -79% $0.000000 2,468 05 Jan 2023 Common Stock 9,467 $0.9830 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022.
F2 The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.00 to $5.47, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F3 The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.00 to $5.19, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F4 The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.00 to $5.14, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F5 This option is fully vested and exercisable.